Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention

Serruys, Patrick WJC; Feyter, Pim de; Macaya, Carlos; Kokott, Norbert; Puel, Jacques; Vrolix, Matthias; Branzi, Angelo; Bertolami, Marcelo C; Jackson, Graham; Strauss, Bradley; Meier, Bernhard.
JAMA ; 287(24): 3215-3223, 2002.
Artículo en Inglés | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1064080

Documentos relacionados

  1. Design of percutaneous transluminal coronary angioplasty balloon catheters.
  2. [Percutaneous transluminal coronary angioplasty: from revolution to evolution].
  3. Comparison of long-term outcomes of double kissing crush versus T and minimal protrusion techniques in complex bifurcation lesions: The EVOLUTE-CRUSH II registry.
  4. [Clinical values of ST-segment changes in ST-segment elevated myocardial infarction patients within 24 hours post primary percutaneous coronary interventions].
  5. Current Perspectives in Facilitated Angioplasty.
  6. Benefits of excimer laser coronary angioplasty over thrombus aspiration therapy for patients with acute coronary syndrome and thrombolysis in myocardial infarction flow grade 0.
  7. Critical evaluation of stents in coronary angioplasty: a systematic review.
  8. The efficacy of modified jailed balloon technique for true bifurcation lesions.
  9. Current approaches to retroperitoneal hemorrhage: Too little, too late.
  10. An algorithmic approach to balloon-uncrossable coronary lesions.